المؤلفون: M Ortiz-Estévez, Fadi Towfic, Mehmet Kemal Samur, Hervé Avet-Loiseau, Anjan Thakurta, NC Munshi, Trotter Mwb., Gareth J. Morgan, I S Jang, Kai Wang, Brian A Walker, N Stong, Paresh Vyas, Erin Flynt

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Genetic heterogeneity, DNA repair, Disease, Drug resistance, Cell cycle, Biology, medicine.disease, Genome, Internal medicine, medicine, Copy-number variation, Multiple myeloma

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::61277c66fe63d1a32650317de8c78f9f
https://doi.org/10.21203/rs.3.rs-923792/v1

المؤلفون: Brons, IGM, Smithers, LE, Trotter, MWB, Rugg-Gunn, P, Sun, BW, Lopes, SMCD, Howlett, SK, Clarkson, A, Ahrlund-Richter, L, Pedersen, RA, Vallier, L

المصدر: Nature. 448(7150):191-U7

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:115500635

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Abbiati RA; Bristol Myers Squibb, Center for Innovation and Translational Research Europe (CITRE), Seville, Spain. roberto.abbiati@bms.com., Pourdehnad M; Bristol Myers Squibb, San Francisco, California, USA., Carrancio S; Bristol Myers Squibb, San Diego, California, USA., Pierce DW; Bristol Myers Squibb, San Diego, California, USA., Kasibhatla S; Bristol Myers Squibb, San Diego, California, USA., McConnell M; Bristol Myers Squibb, Seattle, Washington, USA., Trotter MWB; Bristol Myers Squibb, Center for Innovation and Translational Research Europe (CITRE), Seville, Spain., Loos R; Bristol Myers Squibb, Center for Innovation and Translational Research Europe (CITRE), Seville, Spain., Santini CC; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland., Ratushny AV; Bristol Myers Squibb, Seattle, Washington, USA. alexander.ratushnyy@bms.com.

المصدر: The AAPS journal [AAPS J] 2022 Jan 14; Vol. 24 (1), pp. 29. Date of Electronic Publication: 2022 Jan 14.

نوع المنشور: Published Erratum

بيانات الدورية: Publisher: American Association of Pharmaceutical Scientists Country of Publication: United States NLM ID: 101223209 Publication Model: Electronic Cited Medium: Internet ISSN: 1550-7416 (Electronic) Linking ISSN: 15507416 NLM ISO Abbreviation: AAPS J Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: Ortiz-Estévez M; BMS Center for Innovation and Translational Research Europe (CITRE), A Bristol Myers Squibb Company, Sevilla, Spain., Towfic F; Bristol Myers Squibb, San Diego, CA, USA., Flynt E; Bristol Myers Squibb, 181 Passaic Ave, Summit, NJ, 07901, USA., Stong N; Bristol Myers Squibb, 181 Passaic Ave, Summit, NJ, 07901, USA., Jang IS; Bristol Myers Squibb, San Diego, CA, USA., Wang K; Bristol Myers Squibb, San Diego, CA, USA., Trotter MWB; BMS Center for Innovation and Translational Research Europe (CITRE), A Bristol Myers Squibb Company, Sevilla, Spain., Thakurta A; Bristol Myers Squibb, 181 Passaic Ave, Summit, NJ, 07901, USA. anjan.thakurta@bms.com.

المصدر: BMC medical genomics [BMC Med Genomics] 2021 Dec 18; Vol. 14 (1), pp. 295. Date of Electronic Publication: 2021 Dec 18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101319628 Publication Model: Electronic Cited Medium: Internet ISSN: 1755-8794 (Electronic) Linking ISSN: 17558794 NLM ISO Abbreviation: BMC Med Genomics Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/epidemiology , Multiple Myeloma*/genetics, Cell Cycle/genetics ; DNA Damage/genetics ; DNA Repair/genetics ; Genomics/methods ; Humans ; Risk

المؤلفون: Abbiati RA; Bristol Myers Squibb, Center for Innovation and Translational Research Europe (CITRE), Seville, Spain. roberto.abbiati@bms.com., Pourdehnad M; Bristol Myers Squibb, San Francisco, California, USA., Carrancio S; Bristol Myers Squibb, San Diego, California, USA., Pierce DW; Bristol Myers Squibb, San Diego, California, USA., Kasibhatla S; Bristol Myers Squibb, San Diego, California, USA., McConnell M; Bristol Myers Squibb, Seattle, Washington, USA., Trotter MWB; Bristol Myers Squibb, Center for Innovation and Translational Research Europe (CITRE), Seville, Spain., Loos R; Bristol Myers Squibb, Center for Innovation and Translational Research Europe (CITRE), Seville, Spain., Santini CC; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center, Basel, Switzerland., Ratushny AV; Bristol Myers Squibb, Seattle, Washington, USA. alexander.ratushnyy@bms.com.

المصدر: The AAPS journal [AAPS J] 2021 Aug 27; Vol. 23 (5), pp. 103. Date of Electronic Publication: 2021 Aug 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association of Pharmaceutical Scientists Country of Publication: United States NLM ID: 101223209 Publication Model: Electronic Cited Medium: Internet ISSN: 1550-7416 (Electronic) Linking ISSN: 15507416 NLM ISO Abbreviation: AAPS J Subsets: MEDLINE

مواضيع طبية MeSH: Models, Biological*, Antineoplastic Agents/*adverse effects , Neutropenia/*prevention & control , Piperidones/*adverse effects , Quinazolinones/*adverse effects, Antineoplastic Agents/administration & dosage ; Biological Variation, Population ; Computer Simulation ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Humans ; Network Pharmacology ; Neutropenia/chemically induced ; Neutropenia/immunology ; Neutrophils/drug effects ; Neutrophils/immunology ; Piperidones/administration & dosage ; Quinazolinones/administration & dosage

المؤلفون: Wall MA; Institute for Systems Biology, Seattle, WA, USA., Turkarslan S; Institute for Systems Biology, Seattle, WA, USA., Wu WJ; Institute for Systems Biology, Seattle, WA, USA., Danziger SA; Bristol-Myers Squibb, Summit, NJ, USA., Reiss DJ; Bristol-Myers Squibb, Summit, NJ, USA., Mason MJ; Sage Bionetworks, Seattle, WA, USA., Dervan AP; Bristol-Myers Squibb, Summit, NJ, USA., Trotter MWB; Celgene Institute for Translational Research Europe (CITRE), a Bristol-Myers Squibb Company, Summit, NJ, USA., Bassett D; Bristol-Myers Squibb, Summit, NJ, USA., Hershberg RM; Celgene Corporation, Seattle, WA, USA., Lomana ALG; Institute for Systems Biology, Seattle, WA, USA. adrian.lopezgarciadelomana@isbscience.org., Ratushny AV; Bristol-Myers Squibb, Summit, NJ, USA. alexander.ratushnyy@bms.com., Baliga NS; Institute for Systems Biology, Seattle, WA, USA. nitin.baliga@isbscience.org.; Departments of Biology, Microbiology, and Molecular Engineering Sciences, University of Washington, Seattle, WA, USA. nitin.baliga@isbscience.org.; Lawrence Berkeley National Labs, Berkeley, CA, USA. nitin.baliga@isbscience.org.

المصدر: NPJ precision oncology [NPJ Precis Oncol] 2021 Jun 28; Vol. 5 (1), pp. 60. Date of Electronic Publication: 2021 Jun 28.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE

المؤلفون: Danziger SA; Bristol Myers Squibb, Seattle, Washington, United States of America., McConnell M; Bristol Myers Squibb, Seattle, Washington, United States of America., Gockley J; Sage Bionetworks, Seattle, Washington, United States of America., Young MH; Sage Bionetworks, Seattle, Washington, United States of America., Rosenthal A; Cancer Research and Biostatistics, Seattle, Washington, United States of America., Schmitz F; Sage Bionetworks, Seattle, Washington, United States of America., Reiss DJ; Bristol Myers Squibb, Seattle, Washington, United States of America., Farmer P; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America., Alapat DV; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America., Singh A; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America., Ashby C; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America., Bauer M; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America., Ren Y; Bristol Myers Squibb, Seattle, Washington, United States of America., Smith K; Bristol Myers Squibb, Seattle, Washington, United States of America., Couto SS; Genmab, Princeton, New Jersey, United States., van Rhee F; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America., Davies F; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America., Zangari M; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America., Petty N; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America., Orlowski RZ; The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America., Dhodapkar MV; Winship Cancer Institute, Emory University, Atlanta, Georgia, United States of America., Copeland WB; Bristol Myers Squibb, Seattle, Washington, United States of America., Fox B; Bristol Myers Squibb, Seattle, Washington, United States of America., Hoering A; Cancer Research and Biostatistics, Seattle, Washington, United States of America., Fitch A; Bristol Myers Squibb, Seattle, Washington, United States of America., Newhall K; Sage Bionetworks, Seattle, Washington, United States of America., Barlogie B; Department of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America., Trotter MWB; BMS Center for Innovation and Translational Research Europe (CITRE), Seville, Spain., Hershberg RM; Sage Bionetworks, Seattle, Washington, United States of America., Walker BA; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America., Dervan AP; Sage Bionetworks, Seattle, Washington, United States of America., Ratushny AV; Bristol Myers Squibb, Seattle, Washington, United States of America., Morgan GJ; Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America.

المصدر: PLoS medicine [PLoS Med] 2020 Nov 04; Vol. 17 (11), pp. e1003323. Date of Electronic Publication: 2020 Nov 04 (Print Publication: 2020).

نوع المنشور: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360 Publication Model: eCollection Cited Medium: Internet ISSN: 1549-1676 (Electronic) Linking ISSN: 15491277 NLM ISO Abbreviation: PLoS Med Subsets: MEDLINE

مواضيع طبية MeSH: Tumor Microenvironment*, Bone Marrow/*pathology , Multiple Myeloma/*diagnosis , Multiple Myeloma/*pathology, Adult ; Cohort Studies ; Female ; Humans ; Male ; Middle Aged ; Multiple Myeloma/drug therapy ; Prognosis ; Tumor Burden